Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FW79Z
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,585
Award facts
- Contract value 100% obligated
- $14,584.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 28, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a ceiling value of $14,584.77. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for delivery to Conshohocken, Pennsylvania, with an ultimate completion date of April 29, 2025. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026, which serves as the primary pharmaceutical supply vehicle for the Defense Logistics Agency's global medical procurement needs.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC enables AmerisourceBergen to supply pharmaceutical products to support Defense Health Agency operations and other government healthcare systems worldwide, with flexibility to serve diverse medical supply requirements across multiple service branches and allied government agencies.
Quick answers
Who was awarded contract SPE2DB25FW79Z?
SPE2DB25FW79Z was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 28, 2025.
How much is contract SPE2DB25FW79Z worth?
The government has obligated $14,585 on SPE2DB25FW79Z.
Is contract SPE2DB25FW79Z an order under another contract?
Yes. SPE2DB25FW79Z is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW79Z competed?
The extent of competition for SPE2DB25FW79Z was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award